The Disappointment of China's BioMed Secotr
Filed in archive Venture Capital by Greg Cruey on July 23, 2008
The comparison is simple enough. In the U.S., biomedical projects rake in 31% of all venture capital funding. In China, only 2.4% of venture capital funding went to biomedical and/or healthcare projects in the recently released Q2 numbers.
Everyone keeps waiting and predicting that the biomedical take of VC funds in China will start to climb. So far it hasn't...

© Patrick J. Lynch
Permalink: The Disappointment of China's BioMed Secotr
Tags:
biomed vc venture capital
Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/129399












